David Pepin

David Pepin was trained as a molecular and developmental biologist at the University of Ottawa, Canada, where he completed a Ph.D. elucidating the role of chromatin remodeling during ovarian development and in ovarian cancers. In 2011, Dr. Pepin joined the Pediatric Surgical Research Laboratories as a Research Fellow at the Massachusetts General Hospital, in Boston to continue his training in ovarian cancer research. In 2016 Dr. Pepin established is laboratory as an Assistant Professor in the Pediatric Surgical Research Laboratories of the Massachusetts General Hospital. His research focuses on women’s health and particularly female reproductive development, ovarian physiology, and ovarian cancer.

Education

• Post-Doctoral Fellow Harvard Medical School (2011 — 2013)
• Ph.D University of Ottawa / Université d'Ottawa (2003 — 2010)
• Bachelor of Science (B.Sc.) University of Ottawa / Université d'Ottawa (1999 — 2003)

Companies

• Associate Professor Harvard Medical School and Massachusetts General Hospital (2021)
• Co-Founder & Scientific Advisor Oviva Therapeutics (2021)
• Associate Molecular Biologist Massachusetts General Hospital (2020)
• Associate Director, Pediatric Surgical Research Laboratories Massachusetts General Hospital (2019)
• Assistant Professor Harvard Medical School and Massachusetts General Hospital (2016 — 2021)
• co-founder Provulis LLC (2015 — 2020)
• Instructor, Assistant in Surgery Harvard Medical School (2014 — 2016)
• Research Fellow Massachusetts General Hospital (2010 — 2014)
• Lecturer Ottawa University (2009 — 2011)